Literature DB >> 24080500

In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase.

Neil Woodford1, Rachel Pike, Daniele Meunier, Richard Loy, Robert Hill, Katie L Hopkins.   

Abstract

Entities:  

Keywords:  ESBLs; Enterobacteriaceae; KPC; NDM; VIM

Mesh：

Substances：

Year:  2013        PMID： 24080500     DOI： 10.1093/jac/dkt383

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  21 in total

1.  Resurrecting Old β-Lactams: Potent Inhibitory Activity of Temocillin against Multidrug-Resistant Burkholderia Species Isolates from the United States.

Authors:  Elise T Zeiser; Scott A Becka; Melissa D Barnes; Magdalena A Taracila; John J LiPuma; Krisztina M Papp-Wallace
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

Review 2.  Pharmacokinetics and Pharmacodynamics of Temocillin.

Authors:  Kevin Alexandre; Bruno Fantin
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

3.  Activity of temocillin, mecillinam, ceftazidime, and ceftazidime/avibactam against carbapenem-non-susceptible Enterobacteriaceae without carbapenemase production.

Authors:  N T Mutters; S Zimmermann; M Kaase; A Mischnik
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-10-03       Impact factor: 3.267

4.  In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase.

Authors:  David M Livermore; Marina Warner; Dorota Jamrozy; Shazad Mushtaq; Wright W Nichols; Nazim Mustafa; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

Review 5.  Insights into Newer Antimicrobial Agents Against Gram-negative Bacteria.

Authors:  Neelam Taneja; Harsimran Kaur
Journal:  Microbiol Insights       Date:  2016-03-20

Review 6.  Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

Authors:  Jesús Rodríguez-Baño; Belén Gutiérrez-Gutiérrez; Isabel Machuca; Alvaro Pascual
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

7.  Comparison of Phenotypic Tests and an Immunochromatographic Assay and Development of a New Algorithm for Detection of OXA-48-like Carbapenemases.

Authors:  Florian Koroska; Stephan Göttig; Martin Kaase; Jörg Steinmann; Sören Gatermann; Julian Sommer; Thorsten Wille; Georg Plum; Axel Hamprecht
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

8.  Evaluation of a new phenotypic OXA-48 disk test for differentiation of OXA-48 carbapenemase-producing Enterobacteriaceae clinical isolates.

Authors:  Athanassios Tsakris; Aggeliki Poulou; Pierre Bogaerts; Evangelia Dimitroulia; Spyros Pournaras; Youri Glupczynski
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

Review 9.  Treatment of Infections by OXA-48-Producing Enterobacteriaceae.

Authors:  Adam Stewart; Patrick Harris; Andrew Henderson; David Paterson
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

10.  Epidemiology and control measures of an OXA-48-producing Enterobacteriaceae hospital outbreak.

Authors:  Anand Sivaramakrishnan; Damien Mack; Husam El-Mugamar; Judy Jacques; Stephanie Paget; Lynette Phee; Yvonne Carter
Journal:  Infect Prev Pract       Date:  2020-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.